Major order for Gerresheimer

Production of components for more Sanofi insulin pens

Düsseldorf/Wackersdorf April 16, 2013: Gerresheimer started the production of components for a new order of insulin pens from healthcare company Sanofi. The preparations for the production – including the construction of a new production hall at Gerresheimer’s facility in Horšovský Týn, Czech Republic, as well as all required qualifications and validations – were completed within only eighteen months.

The structural components for the disposable insulin pen manufactured in the new hall consist of several plastic parts which were manufactured by Gerresheimer at Medical Plastic Systems, and a bought-in bending spring. The final pen assembly is carried out at Sanofi’s facility in Frankfurt/Main in Germany.

The production and assembly of the structural components involves injection molding machines, removal robots, different measuring and testing systems as well as pad printing lines. The complex and highly automated assembly line with several assembly and testing stations was planned and installed entirely by Gerresheimer Medical Plastic Systems. The specialist also developed several of the required molds. These were manufactured by their in-house mold engineering department. Especially for this project, the manufacturer built a new hall with 3,500 sqm clean room areas to ISO class 8 for production and assembly as well as a fully automatic high-rack storage facility.

Gerresheimer Medical Plastic Systems implemented the project including all qualification and validations required for medical technology projects within only eighteen months. For Carsten Dormeier, Project Manager at the Technical Competence Center of Gerresheimer Regensburg GmbH in Wackersdorf/Germany, the adherence to the extremely tight schedule is the most impressive achievement of the project: “We were able to adhere to the ambitious schedule of this extensive project from the start of the planning phase in Wackersdorf through to production startup in Horšovský Týn thanks to the high commitment of our staff at both facilities.” The high speed of development will be maintained.

The new project is the second Sanofi order for the production of insulin pens from Gerresheimer. Reusable pens are already manufactured at the company’s Pfreimd facility.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.

Our Group realizes revenues of around EUR 1.2 bn and has approxiamately 11,000 employees at 47 locations in Europe, North and South America and Asia.  We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.

Contact
Marion Stolzenwald
Gerresheimer AG
Benrather Straße 18-20
40213 Düsseldorf
Phone 0211-6181246 
Fax 0211-6181241 
E-Mail: m.stolzenwald-remove@remove-gerresheimer.com

Karin Strasser
Gerresheimer Regensburg GmbH
Oskar-von-Miller-Straße 6
92442 Wackersdorf
Phone 09431-639 6140
Fax 09431-79838-6140
E-Mail: k.strasser-remove@remove-gerresheimer.com

Contact us!

Communication & Marketing
Phone: +49 211 61 81 251
E-Mail: ueli.utzinger-remove@remove-gerresheimer.com